Biomedicines Webinar | Emerging Trends in Pathophysiology and Therapy of COVID-19
the chair
14th Biomedicines Webinar
Emerging Trends in Pathophysiology and Therapy of COVID-19
I am pleased to serve as the Chairman of this webinar on Emerging Trends in Pathophysiology and Therapy of COVID-19.
Although the worst of the SARS CoV-2 pandemic is behind us, many questions and issues persist. Systemic manifestations due to COVID-19 infections and long COVID continue to emerge in multiple countries. There are a few new USA FDA-approved vaccines available in addition to the Moderna, Pfizer, and Johnson and Johnson ones, but vaccine effectiveness and immunologic memory appear to be limited in most patients.
Therapies are available and should be incorporated into treatment plans for COVID-19 patients. Although the focus of these therapies is on hospitalized COVID-19 patients, orally delivered medications are now administered by health care providers.
This webinar will present discussions on these issues, as well as emerging trends, to understand COVID-19 infections and transmissibility more fully.
Date: 4 June 2024 at 5:00 CEST | 11:00 a.m. EDT | 11:00 p.m. CST AsiaWebinar ID: 828 4947 7200
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chair
Important Dates
- Registration end dateJun 04, 2024
Meet Our Speakers
Prof. Dr. Jon Suzuki
University of Maryland, USA, University of Washington, USA, Nova Southeastern University, USA, Temple University, USA;
Prof. Dr. Jon Suzuki holds Clinical Professorships at the University of Maryland, the University of Washington, and Nova Southeastern University. He is Professor Emeritus of Microbiology and Immunology (School of Medicine) and Professor Emeritus of Periodontology and Oral Implantology (School of Dentistry) at Temple University, Philadelphia, PA., USA. He is also a Special Government Agent for the Food and Drug Administration (FDA) Dental Products Advisory Panel. Dr. Suzuki received his D.D.S. from Loyola University of Chicago and his Ph.D. in Microbiology from the Illinois Institute of Technology. He completed an N.I.H. Fellowship in Immunology at the University of Washington, and a Clinical Certificate in Periodontics at the University of Maryland.
Dr. Rosalinda Sorrentino
Department of Pharmacy, University of Salerno, Italy;
Dr. Sorrentino's research focuses on the understanding and analysis of inflammation pathways and immune cells involved in acute and chronic lung pathologies.
Prof. Dr. Stefano D'Errico
Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy;
Active in the fields of forensic pathology and toxicology, bioethics and clinical risk management, and medical liability. Research interests include forensic autopsy technique, forensic pathology, forensic toxicology, cardiopathology, sudden death, and clinical risk management. Expert witness for the Italian Courts. Manager of the Registry of Sudden Cardiac Death in Friuli-Venezia Giulia, Italy.
Dr. Miriana D'Alessandro
Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy;
Dr. D'Alessandro started her research in translational medicine for lung diseases with the project "Interaction between solid lipid nanoparticles and respiratory epithelial cells: in vitro study of uptake and biocompatibility". Since then, D'Alessandro has researched novel biomarkers of diffuse lung diseases, asthma, COVID-19, and lung transplantation. Her research focuses on the immune system in different biological matrices - including bronchoalveolar lavage of fibrotic interstitial lung disease patients and the validation of novel biomarkers such as the Krebs von den Lungen-6 and extracellular vesicles.
Dr. Sara Gangi
Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy;
Dr. Gangi is a PhD candidate in the Respiratory Diseases Unit at the University of Siena. Her project focuses on the analysis of prognostic and diagnostic biomarkers in fibrotic interstitial lung diseases, COVID-19, and lung transplants. Dr. Gangi has developed a good knowledge base on cell culture, flow cytometry analysis, and chemiluminescent methods. She worked on the development of a novel fibroblast cell line isolated by bronchoalveolar lavage of IPF patients. She has authored/coauthored 17 research documents and given lectures at national/international congresses.
Sponsors and Partners
Organizer
MDPI COVID Webinar Synopsis 04 June 2024 As Chairman of this webinar on Emerging Trends in Pathophysiology and Therapy of COVID-19, I am pleased to provide concluding remarks from the landmark MDPI Webinar on current research and findings on SARS CoV-2, COVID-19 Infections.
Systemic manifestations and complications due to COVID-19 infections and long COVID continue to emerge in multiple countries. Current (2024) available published research elucidates further complications and systemic and oral extensions of this disease.
Prof Dr Jon B. Suzuki opened the Webinar Congress with implications of COVID-19 infections as a bi-directional relationship with Periodontal Diseases of the Oral Cavity.
Prof Dr. Rosalinda Sorrentino elaborated on the critical role of Inflamasones and other cytokines in relationship to pulmonary lesions and pulmonary fibrosis.
Prof. Dr. Stefano D’Errico demonstrated with post COVID-19 autopsy data that embolism was a consistent cause of death of COVID-19 patients, with dramatic increases in CD-3 positive and T-cell lymphocytes.
Finally, Prof. Dr. Mariana D’Alessandro defined the role of the viral phase – host immunity on Long COVID with increased ProInflammatory Cytokines including IL-6, TNF-a, and IL-4.
Continued World-wide surveillance of SARS-CoV-2 is critical since long term vaccine effectiveness and immunologic memory appear to be limited in most patients.
Jon B. Suzuki
Summary by Professor Dr. Jon B. Suzuki, DDS, Ph.D., MBA
The webinar was hosted via Zoom and required registration to attend. The full recording can be accessed below. In order to learn about future webinars, you can sign up for our newsletter by clicking “Subscribe” at the top of the page.
In this section, you will find the recordings of this webinar to watch, re-watch and share with your colleagues!
Emerging Trends in Pathophysiology and Therapy of COVID-19
Guest Editors: Dr. Jon B. Suzuki, Dr. Miriam Ting
Deadline for manuscript submissions: 31 October 2024